H. Lenz

发表

Non-canonical MLL1 activity regulates centromeric phase separation and genome stability

Y. Dou, S. An, Hengan Wang, 2023, Nature Cell Biology.

What roles do colon stem cells and gap junctions play in the left and right location of origin of colorectal cancers?

H. Lenz, James E. Trosko, 2017, Journal of cell communication and signaling.

DNA microarray profiling of genes differentially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell lines

Susan Groshen, S. Groshen, H. Lenz, 2009, BMC Medical Genomics.

Gene signatures derived from transcriptomic-causal networks stratified colorectal cancer patients for effective targeted therapy

G. Pillonetto, C. Perou, M. Ratain, 2023, Research square.

Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer.

A. Venook, J. Millstein, F. Ou, 2024, European Journal of Cancer.

q-Diffusion leverages the full dimensionality of gene coexpression in single-cell transcriptomics.

Myrl G. Marmarelis, A. Galstyan, J. Ambite, 2024, Communications biology.

DNA microarray profiling of genes differentially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell lines

P. Wilson, W. Fazzone, M. LaBonte, 2009, BMC Medical Genomics.

Nivolumab + low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142.

E. Van Cutsem, M. Overman, S. Lonardi, 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

Gene expression biomarkers differentiate overall survival of colorectal cancer upon targeted therapies

G. Pillonetto, S. Kopetz, A. Yazdani, 2024, Research square.

Modified FOLFOX6 plus bevacizumab with and without nivolumab for first-line treatment of metastatic colorectal cancer: phase 2 results from the CheckMate 9X8 randomized clinical trial

D. Spigel, A. Parikh, E. Élez, 2024, Journal for ImmunoTherapy of Cancer.

CCR5 and CCL5 gene expression in colorectal cancer: comprehensive profiling and clinical value

Taline Khoukaz, A. Venook, J. Millstein, 2024, Journal for immunotherapy of cancer.

DNA Mutational Profiling in Patients With Colorectal Cancer Treated With Standard of Care Reveals Differences in Outcome and Racial Distribution of Mutations.

N. Rashid, A. Venook, F. Ou, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Botensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trial.

G. Abou-Alfa, A. El-Khoueiry, A. Tsimberidou, 2024, Nature medicine.

A revised nomenclature for the lemur family of protein kinases

G. Giamas, O. Caluseriu, S. Hisanaga, 2024, Communications biology.

Nivolumab (NIVO) plus ipilimumab (IPI) vs chemotherapy (chemo) as first-line (1L) treatment for microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC): First results of the CheckMate 8HW study.

G. Tortora, R. García-Carbonero, T. Yoshino, 2024, Journal of Clinical Oncology.

Overcoming Systemic Barriers to Make Patient-Partnered Research a Reality.

K. Janeway, Liz Salmi, Vinayak Venkataraman, 2024, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Exploring Predictive and Prognostic Biomarkers in Colorectal Cancer: A Comprehensive Review

Taline Khoukaz, J. Millstein, Jae Ho Lo, 2024, Cancers.

Consensus molecular subtyping of metastatic colorectal cancer expands biomarker-directed therapeutic benefit for patients with CMS1 and CMS2 tumors.

M. Oberley, D. Spetzler, K. Poorman, 2024, British journal of cancer.

Understanding patient-derived tumor organoid growth through an integrated imaging and mathematical modeling framework.

S. Mumenthaler, Brandon Choi, Seung-Jin Kim, 2024, PLoS computational biology.

A phase II study of guadecitabine combined with irinotecan vs regorafenib or TAS‐102 in irinotecan‐refractory metastatic colorectal cancer patients

A. Cercek, R. Parkinson, N. Azad, 2024, International journal of cancer.

Merging Metabolic Modeling and Imaging for Screening Therapeutic Targets in Colorectal Cancer

Stacey D. Finley, P. Macklin, N. Graham, 2024, bioRxiv.

Fine-mapping analysis including over 254,000 East Asian and European descendants identifies 136 putative colorectal cancer susceptibility genes

Stephanie A. Bien, I. Deary, A. Kundaje, 2024, Nature communications.